Schizophrenia Research
Volume 52, Issue 3 , Pages 167-170, 1 December 2001

Screening for 22q11 deletions in a schizophrenia population

  • T. Arinami

      Affiliations

    • Department of Medical Genetics, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-298-53-3352; fax: +81-298-53-3333
  • ,
  • T. Ohtsuki

      Affiliations

    • Department of Medical Genetics, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
  • ,
  • K. Takase

      Affiliations

    • Department of Medical Genetics, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
  • ,
  • H. Shimizu

      Affiliations

    • Hokushin General Hospital, Nakano 383-8505, Japan
  • ,
  • T. Yoshikawa

      Affiliations

    • Laboratory for Molecular Psychiatry, RIEKN Brain Science Institute, Wako 351-0198, Japan
  • ,
  • H. Horigome

      Affiliations

    • Department of Medical Genetics, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
    • Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
  • ,
  • J. Nakayama

      Affiliations

    • Department of Medical Genetics, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
    • Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
  • ,
  • M. Toru

      Affiliations

    • Department of Neuropsychiatry, Tokyo Medical and Dental University School of Medicine, Tokyo 113-8510, Japan

Received 21 October 2000; accepted 4 December 2000.

Abstract 

Since the recognition that adults with velocardiofacial syndrome (VCFS), which is associated with hemizygous interstitial deletions of chromosome 22q11, frequently show psychotic symptoms, deletion of the 22q11.2 region has been proposed as a common genetic abnormality associated with schizophrenia. In studies of schizophrenia patients, such deletions have been detected in more than 1% of schizophrenics, indicating the likely presence of this deletion in a significant number of patients. In this study, we screened for 22q11.2 deletions by genotyping microsatellite markers in 300 schizophrenics and 300 normal controls. The 22q11.2 deletion was confirmed by fluorescent in situ hybridization (FISH). One patient with schizophrenia was found to have a 22q11.2 deletion. The patient was mildly retarded but did not have craniofacial, palatal, or cardiac malformations characteristic of VCFS. Our results indicate that 22q11.2 deletion does not contribute substantially to the development of schizophrenia in general. However, our findings establish the existence of physically near-normal individuals with 22q11.2 deletion among learning disabled or mildly retarded persons with schizophrenia.

Keywords:  Schizophrenia, Chromosome 22q11, Velocardiofacial syndrome, FISH, Microsatellite

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(00)00192-4

Schizophrenia Research
Volume 52, Issue 3 , Pages 167-170, 1 December 2001